Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1027 |
---|---|
Product Name | Anti-Human CEACAM5 Recombinant Antibody |
Molecular Name | Labetuzumab |
Alias | Anti-CEACAM5 Recombinant Antibody, Research Grade Labetuzumab |
CAS Number | 219649-07-7 |
Target | CEACAM5[Homo sapiens] |
Isotype | IgG |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Buffer | PBS, pH7.5 |
Background | Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer. It selectively binds to carcinoembryonic cell adhesion molecule 5. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |